New website and digital outreach initiative connect patients, families and healthcare providers with Alpha-1 education, advocacy resources and specialized care
GREENSBORO, N.C., Oct. 14, 2026 /PRNewswire-PRWeb/ -- AvevoRx, a national, independent provider of specialty infusion pharmacy services, today announced the launch of a new digital platform dedicated exclusively to Alpha-1 Antitrypsin Deficiency (AATD), expanding the company's efforts to connect patients, families and healthcare providers with specialized education, advocacy and treatment support.
The new platform, located at AvevoRxAlpha.com, serves as a centralized online resource for people recently diagnosed with Alpha-1, patients seeking specialized treatment and support, and physicians looking to connect patients with experienced Alpha-1 care.
The website is part of a broader Alpha-1 digital outreach initiative that includes dedicated social media channels, educational content, and targeted outreach to patients and healthcare providers nationwide. The effort builds on AvevoRx's expansion earlier this year of its national Alpha-1 Advocacy Program and increased investment in patient education and physician engagement.
"Some Alpha-1 patients come to us after spending years navigating a complex healthcare system, and even after diagnosis, they may have questions about treatment, insurance, financial assistance, and what comes next," said Ric Logsdon, Senior Director and Alpha-1 Program Manager at AvevoRx. "We wanted to create a convenient resource that makes those answers easier to find while giving patients a direct connection to people who understand Alpha-1 and the challenges they face. The goal is to make the entire experience simpler and more personal."
Alpha-1 is an inherited genetic condition that can affect the lungs and liver and remains significantly underdiagnosed in the United States. Patients may be treated for symptoms for years before clinicians identify the underlying condition, delaying access to appropriate treatment and long-term disease management. AvevoRx's Alpha-1 program combines specialty pharmacy services with dedicated patient advocacy, education, insurance coordination, and financial assistance navigation.
Designed for both patients and physicians, the new AvevoRx Alpha-1 website provides easy access to information and resources based on each audience's needs. Patients can learn more about Alpha-1, treatment and infusion therapy, family testing, financial assistance, and AvevoRx's patient advocacy services. Physicians and their staff can access information about Alpha-1 care and treatment and quickly connect with AvevoRx to initiate a patient referral.
The platform also provides patients with a direct pathway to a dedicated Alpha-1 advocate. AvevoRx assigns Alpha-1 patients a consistent point of contact who can help them understand the treatment process, navigate insurance requirements and authorizations, identify financial assistance resources, and coordinate ongoing care.
"Patients shouldn't have to navigate Alpha-1 care on their own, and physicians and staff shouldn't have to shoulder every administrative burden involved in getting patients started and keeping them on therapy," said Lauren Pumphrey, co-founder of AvevoRx. "Our Alpha-1 program is built around removing those barriers and providing consistent, personalized support throughout the care journey. This new platform gives us another way to extend that level of support to patients and providers nationwide."
AvevoRx is the only privately held specialty pharmacy provider with access to all four FDA-approved Alpha-1 augmentation therapies and offers patients access to a nationwide network of more than 270 nurses. Its Alpha-1 advocates focus exclusively on the condition, providing specialized support throughout patients' care journey.
The initiative expands on AvevoRx's broader investment in digital education and patient engagement. Earlier this year, the company launched a dedicated nutrition resource platform and national outreach initiative designed to connect patients with complex gastrointestinal disorders to specialized nutrition expertise and support.
To learn more about AvevoRx's Alpha-1 program and access the new platform, visit AvevoRxAlpha.com.
About AvevoRx
AvevoRx is a national, independent provider of specialty infusion pharmacy services. The company focuses on delivering the highest-quality, personalized care customized to patients with complex, chronic disorders. Treatments are delivered through specialized pharmacy locations, experienced field nurses and dedicated support staff throughout the United States. AvevoRx also provides acute infusion therapies on a regional basis for patients with short-term therapeutic needs. Founded in 2021 by a group of industry veterans with more than 130 years of combined experience, AvevoRx is headquartered in Greensboro, North Carolina. To learn more, visit www.AvevoRx.com or follow AvevoRx on LinkedIn and Instagram.
Media Contact
Richard Kendall, AvevoRx, 1 6193462084, [email protected], https://avevorx.com/
SOURCE AvevoRx
Share this article